Bio-Rad Laboratories
BIO
$286.86
Share price
1.72%
Change (1 day)
-22.75%
Change (1 year)
Categories
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.
Bio-Rad Laboratories (BIO) - Total debt
Total debt on the balance sheet as of March 2024 : $1.39 B
According to Bio-Rad Laboratories's latest financial reports the company's total debt is $1.39 B. A company’s total debt is the sum of all current and non-current debts.
Bio-Rad Laboratories - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.40 B | 1.25% |
| 2022-12-31 | $1.38 B | 521.42% |
| 2021-12-31 | $0.22 B | -1.05% |
| 2020-12-31 | $0.22 B | -65.33% |
| 2019-12-31 | $0.65 B | 48.19% |
| 2018-12-31 | $0.43 B | 1.02% |
| 2017-12-31 | $0.43 B | 0.11% |
| 2016-12-31 | $0.43 B | 0.08% |
| 2015-12-31 | $0.43 B | -0.41% |
| 2014-12-31 | $0.43 B | -0.33% |
| 2013-12-31 | $0.43 B | -40.42% |
| 2012-12-31 | $0.73 B | 0.23% |
| 2011-12-31 | $0.73 B | -24.04% |
| 2010-12-31 | $0.96 B | 29.77% |
| 2009-12-31 | $0.74 B | 63.11% |
| 2008-12-31 | $0.45 B | -0.41% |
| 2007-12-31 | $0.45 B | 6.71% |
| 2006-12-31 | $0.42 B | -0.08% |
| 2005-12-31 | $0.42 B | -1.47% |
| 2004-12-31 | $0.43 B | 84.31% |
| 2003-12-31 | $0.23 B | 108.61% |
| 2002-12-31 | $0.11 B | -42.9% |
| 2001-12-31 | $0.19 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 2,302.73% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $35.60 B | 2,443.90% | 🇺🇸 USA |
 Agilent Technologies A | $2.55 B | 82.53% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.01 B | 1,186.74% | 🇺🇸 USA |
 General Electric GE | $20.52 B | 1,366.34% | 🇺🇸 USA |
 Danaher DHR | $18.16 B | 1,197.60% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.50 B | 222.19% | 🇺🇸 USA |